Publication

Article

Digital Edition

Ophthalmology Times: July 15, 2020
Volume45
Issue 12

Diagnosing a 'down looker'

Author(s):

Jon Carter

Diagnosing a 'down looker'

Diagnosing a 'down looker'


See more Optic Relief content by Jon Carter

Download Issue PDF
Articles in this issue
Aspheric, aberration-free IOL leverages technology for performance
Aspheric, aberration-free IOL leverages technology for performance
Emerging opportunities — and risks — with telehealth in a pandemic
Emerging opportunities — and risks — with telehealth in a pandemic
Figure 1: The Tecnis Toric II lens has an edge of the haptic that is unpolished to create more friction
Toric stability: A minor change with a major impact for patients
Teaching AI algorithms to identify corneal pathology: The future is now
Teaching AI algorithms to identify corneal pathology: The future is now
Diagnosing a 'down looker'
Diagnosing a 'down looker'
A hands-free treatment regimen is found to be safe and effective compared with a conventional eyedrop regimen.
Dropless, hands-free regimen key for patients
Amid pandemic, friendly bugs can help protect the eye from infection
Amid pandemic, friendly bugs can help protect the eye from infection
(Figure 1) These images show the remaining island of residual tissue targeted by gene therapy at treatment. The image at left is 1 week after treatment. (Photos courtesy of M. Dominik Fischer, MD, PhD)
Gene therapy offers hope for choroideremia
Machine-learning algorithms could help predict course of NPDR
Machine-learning algorithms could help predict course of NPDR
Thyroid eye disease: Not limited to visual impairment
Thyroid eye disease: Not limited to visual impairment
Beating burnout with camaraderie
Beating burnout with camaraderie
Themistocles: Everyone's second chance
Themistocles: Everyone's second chance
IOP homeostasis in glaucoma: Looking below the surface
IOP homeostasis in glaucoma: Looking below the surface
Clearing hurdles to large scale telemedicine adoption
Clearing hurdles to large scale telemedicine adoption
A patient's vision loss leads to another diagnosis
The eyes offer conjunctival clue to COVID-19

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
Related Content
Q&A: Siegfried Priglinger, MD, on the long-term outcomes of gene therapy in preschool kids
June 9th 2025

Q&A: Siegfried Priglinger, MD, on the long-term outcomes of gene therapy in preschool kids

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

GenEditBio doses first patient in investigator-initiated trial of GEB-101 for TGFBI corneal dystrophy
June 9th 2025

GenEditBio doses first patient in investigator-initiated trial of GEB-101 for TGFBI corneal dystrophy

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Q&A: Jay Chhablani, MD, discusses 3D choroidal vasculature analysis
June 8th 2025

Q&A: Jay Chhablani, MD, discusses 3D choroidal vasculature analysis

A reviews of the TEASE-1 clinical trial with Benjamin Bakall, MD, PhD
June 7th 2025

A reviews of the TEASE-1 clinical trial with Benjamin Bakall, MD, PhD

© 2025 MJH Life Sciences

All rights reserved.